Log in | Register

Incidence in ICU populations: how to measure and report it?

Jan Beyersmann| Petra Gastmeier| Martin Schumacher
Statistical Note
Volume 40, Issue 6 / June , 2014

Pages 871 - 876

Abstract

Incidence of ICU events is mostly measured in one of two ways which differ by the denominator only. Either the number of incident events divided by the number of ICU patients is reported or the number of incident events per 1,000 ICU days is calculated. The difference is relevant, but a connection is rarely made. We give an example where pneumonia diagnosis on admission has no effect on one measure of mortality incidence, but increases the other. We demonstrate how to connect the two measures of incidence. The conclusion is that so-called ‘competing incidences’ should also be reported.

Keywords

References

  1. Beyersmann J, Schumacher M (2008) Time-dependent covariates in the proportional subdistribution hazards model for competing risks. Biostatistics 9:765–776
    • View reference on PubMed
    • View reference on publisher's website
  2. Beyersmann J, Gastmeier P, Grundmann H, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M (2006) Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 27:493–499
    • View reference on PubMed
    • View reference on publisher's website
  3. Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M (2011) Application of multistate models in hospital epidemiology: advances and challenges. Biom J 53:332–350
    • View reference on PubMed
    • View reference on publisher's website
  4. Beyersmann J, Allignol A, Schumacher M (2012) Competing risks and multistate models with R. Springer, New York
  5. Chevret S (2001) Logistic or cox model to identify risk factors of nosocomial infection: still a controversial issue. Intensiv Care Med 27(10):1559–1560
    • View reference on publisher's website
  6. Eggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D (2003) Ventilator-associated pneumonia: caveats for benchmarking. Intensiv Care Med 29(11):2086–2089
    • View reference on publisher's website
  7. Grambauer N, Schumacher M, Dettenkofer M, Beyersmann J (2010) Incidence densities in a competing events analysis. Am J Epidemiol 172(9):1077–1084
    • View reference on PubMed
    • View reference on publisher's website
  8. Irala-Estévez J, Martínez-Concha D, Díaz-Molina C, Masa-Calles J, del Castillo AS, Navajas RFC (2001) Comparison of different methodological approaches to identify risk factors of nosocomial infection in intensive care units. Intensiv Care Med 27(8):1254–1262
    • View reference on publisher's website
  9. Kestenbaum B (2009) Epidemiology and biostatistics: an Introduction to Clinical Research. Springer, New York
  10. Michel P, Quenon JL, de Sarasqueta AM, Scemama O (2004) Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. Br Med J 328:199–202
    • View reference on publisher's website
  11. Nguile-Makao M, Zahar J, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S et al (2010) Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensiv Care Med 36(5):781–789
    • View reference on publisher's website
  12. Resche-Rigon M, Azoulay E, Chevret S (2006) Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care 10:R5
    • View reference on PubMed
    • View reference on publisher's website
  13. Schoenfeld D (2006) Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies. Crit Care 10(1):103
    • View reference on PubMed
    • View reference on publisher's website
  14. Schoenfeld D, Bernard G et al (2002) Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30(8):1772
    • View reference on PubMed
    • View reference on publisher's website
  15. Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M (2013) Hospital-acquired infections—appropriate statistical treatment is urgently needed! Int J Epidemiol 42(5):1502–1508
    • View reference on PubMed
    • View reference on publisher's website
  16. Turner EL, Hanley JA (2010) Cultural imagery and statistical models of the force of mortality: Addison, gompertz and pearson. J Royal Stat Soc Series A (Stat Soc) 173(3):483–499
    • View reference on publisher's website
  17. Vandenbroucke JP, Pearce N (2012) Incidence rates in dynamic populations. Int J Epidemiol 41:1472–1479
    • View reference on PubMed
    • View reference on publisher's website
  18. Wolkewitz M, Vonberg R, Grundmann H, Beyersmann J, Gastmeier P, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M (2008) Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 12(2):R44
    • View reference on PubMed
    • View reference on publisher's website
  19. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M (2009) Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensiv Care Med 35:826–832. doi:10.1007/s00134-009-1423-6
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement